{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:16:22Z","timestamp":1793834182085,"version":"4.6.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmech.2025.118073","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T16:16:29Z","timestamp":1756397789000},"page":"118073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Fluoromethylcarnitine, a novel inhibitor of trimethylamine levels in trimethylaminuria and trimethylamine N-oxide related disorders"],"prefix":"10.1016","volume":"300","author":[{"given":"Elena","family":"Cini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Vinciarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Del Castello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Dreassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Poggialini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Vagaggini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8660-7580","authenticated-orcid":false,"given":"Maurizio","family":"Taddei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Battistuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Castagnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Viciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Salvini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina","family":"Sidoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Alibrandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118073_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/acs.chemrev.2c00431","article-title":"Microbiome and human health: current understanding, engineering, and enabling technologies","volume":"123","author":"Aggarwal","year":"2023","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.118073_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1021\/acs.jmedchem.7b00244","article-title":"Microbiota\u2013host transgenomic metabolism, bioactive molecules from the inside","volume":"61","author":"Turroni","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118073_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12979-020-00213-w","article-title":"Gut microbiota as the key controllers of \u201chealthy\u201d aging of elderly people","volume":"18","author":"Ragonnaud","year":"2021","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.ejmech.2025.118073_bib4","article-title":"Dysbiosis of the gut microbiota in disease","volume":"26","author":"Carding","year":"2015","journal-title":"Microb. Ecol. Health Dis."},{"key":"10.1016\/j.ejmech.2025.118073_bib5","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1007\/s00394-021-02572-6","article-title":"The use of an in-vitro batch fermentation (human colon) model for investigating mechanisms of TMA production from choline, l-carnitine and related precursors by the human gut microbiota","volume":"60","author":"Day-Walsh","year":"2021","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.ejmech.2025.118073_bib6","volume":"118","author":"Rajakovich","year":"2021"},{"key":"10.1016\/j.ejmech.2025.118073_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40168-017-0271-9","article-title":"Uncovering the trimethylamine-producing bacteria of the human gut microbiota","volume":"5","author":"Rath","year":"2017","journal-title":"Microbiome"},{"key":"10.1016\/j.ejmech.2025.118073_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1146\/annurev-micro-091014-104422","article-title":"Microbiology meets big data: the case of gut microbiota\u2013derived trimethylamine","volume":"69","author":"Falony","year":"2015","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2025.118073_bib9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0278-6915(99)00028-9","article-title":"Dietary precursors of trimethylamine in man: a pilot study","volume":"37","author":"Zhang","year":"1999","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejmech.2025.118073_bib10","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1021\/cb500113p","article-title":"Characterization of choline trimethylamine-lyase expands the chemistry of glycyl radical enzymes","volume":"9","author":"Craciun","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118073_bib11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3109\/00498258709043962","article-title":"The metabolism of 14 C-labelled trimethylamine and its N -oxide in man","volume":"17","author":"Al-waiz","year":"1987","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejmech.2025.118073_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/cdn\/nzaa179","article-title":"Trimethylamine N-oxide (TMAO) is not associated with cardiometabolic phenotypes and inflammatory markers in children and adults","volume":"5","author":"Andraos","year":"2021","journal-title":"Curr. Dev. Nutr."},{"key":"10.1016\/j.ejmech.2025.118073_bib13","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/nu15030759","article-title":"Neither Trimethylamine-N-Oxide nor trimethyllysine is associated with atherosclerosis: a cross-sectional study in older Japanese adults","volume":"15","author":"Bhuiya","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.ejmech.2025.118073_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312511","article-title":"Microbiome-derived trimethylamine N-Oxide (TMAO) as a multifaceted biomarker in cardiovascular disease: challenges and opportunities","volume":"25","author":"Jaworska","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118073_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cmet.2012.12.011","article-title":"Trimethylamine-N-Oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation","volume":"17","author":"Bennett","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejmech.2025.118073_bib16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.31083\/j.rcm2507240","article-title":"Role of trimethylamine N-Oxide in heart failure","volume":"25","author":"Jing","year":"2024","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.ejmech.2025.118073_bib17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/biomedicines11020431","article-title":"Contribution of trimethylamine N-Oxide (TMAO) to chronic inflammatory and degenerative diseases","volume":"11","author":"Constantino-Jonapa","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2025.118073_bib18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jbiosc.2014.03.001","article-title":"Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet","volume":"118","author":"Gao","year":"2014","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.ejmech.2025.118073_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2020.07.010","article-title":"Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes","volume":"47","author":"Le\u00f3n-Mimila","year":"2021","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ejmech.2025.118073_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng1297-491","article-title":"Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome","volume":"17","author":"Dolphin","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmech.2025.118073_bib21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/hmg\/7.5.839","article-title":"Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication","volume":"7","author":"Treacy","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2025.118073_bib22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3390\/biology13120961","article-title":"Exploring trimethylaminuria: genetics and molecular mechanisms, epidemiology, and emerging therapeutic strategies","volume":"13","author":"Sidoti","year":"2024","journal-title":"Biology"},{"key":"10.1016\/j.ejmech.2025.118073_bib23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/bmj.307.6905.655","article-title":"The fish odour syndrome: biochemical, familial, and clinical aspects","volume":"307","author":"Ayesh","year":"1993","journal-title":"Br Med J"},{"key":"10.1016\/j.ejmech.2025.118073_bib24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12889-024-17685-w","article-title":"Living with trimethylaminuria and body and breath malodour: personal perspectives","volume":"24","author":"Flaherty","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ejmech.2025.118073_bib25","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/cmdc.202000571","article-title":"Discovery of a histidine\u2010based scaffold as an inhibitor of gut microbial choline trimethylamine\u2010lyase","volume":"15","author":"Gabr","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118073_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/cbdd.13775","article-title":"Peptidomimetic\u2010based approach toward inhibitors of microbial trimethylamine lyases","volume":"97","author":"Gabr","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2025.118073_bib27","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1021\/acsmedchemlett.0c00005","article-title":"Discovery of a cyclic choline analog that inhibits anaerobic choline metabolism by human gut bacteria","volume":"11","author":"Bollenbach","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118073_bib28","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1039\/D0MD00218F","article-title":"A benzoxazole derivative as an inhibitor of anaerobic choline metabolism by human gut microbiota","volume":"11","author":"Gabr","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118073_bib29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41591-018-0128-1","article-title":"Development of a gut microbe\u2013targeted nonlethal therapeutic to inhibit thrombosis potential","volume":"24","author":"Roberts","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2025.118073_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/jacs.8b04883","article-title":"Structure-guided identification of a small molecule that inhibits anaerobic choline metabolism by human gut bacteria","volume":"141","author":"Orman","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118073_bib31","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1080\/17460441.2021.1933427","article-title":"Applications of fluorine to the construction of bioisosteric elements for the purposes of novel drug discovery","volume":"16","author":"Richardson","year":"2021","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118073_bib32","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1039\/C3CC47581F","article-title":"Fluoromethylated derivatives of carnitine biosynthesis intermediates \u2013 synthesis and applications","volume":"50","author":"Rydzik","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2025.118073_bib33","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1016\/S0040-4039(01)00780-8","article-title":"Asymmetric synthesis of (R)-(-)-carnitine","volume":"42","author":"Jain","year":"2001","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.118073_bib34","doi-asserted-by":"crossref","first-page":"11798","DOI":"10.1039\/C9CC04901K","article-title":"HPLC-free in situ 18 F-fluoromethylation of bioactive molecules by azidation and MTBD scavenging","volume":"55","author":"Lu","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2025.118073_bib35","article-title":"Targeting the gut to protect the heart","volume":"15","author":"Le Bras","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejmech.2025.118073_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.lfs.2014.09.028","article-title":"Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation","volume":"117","author":"Kuka","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2025.118073_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bcp.2004.02.036","article-title":"Cell-, tissue-, sex- and developmental stage-specific expression of mouse flavin-containing monooxygenases (Fmos)","volume":"68","author":"Janmohamed","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118073_bib38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.apradiso.2016.07.021","article-title":"Preclinical acute toxicity, biodistribution, pharmacokinetics, radiation dosimetry and microPET imaging studies of [18F]fluorocholine in mice","volume":"116","author":"Silveira","year":"2016","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ejmech.2025.118073_bib39","first-page":"92","article-title":"Pharmacokinetics and radiation dosimetry of 18 F-Fluorocholine","volume":"43","author":"Degrado","year":"2002","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2025.118073_bib40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jbt.2570100308","article-title":"Gender differences in hepatic expression of flavin\u2010containing monooxygenase isoforms (FMO1, FMO3, and FMO5) in mice","volume":"10","author":"Falls","year":"1995","journal-title":"J. Biochem. Toxicol."},{"key":"10.1016\/j.ejmech.2025.118073_bib41","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.mex.2017.09.004","article-title":"A highly sensitive liquid chromatography electrospray ionization mass spectrometry method for quantification of TMA, TMAO and creatinine in mouse urine","volume":"4","author":"Veeravalli","year":"2017","journal-title":"MethodsX"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:14:22Z","timestamp":1760022862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425008384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":41,"alternative-id":["S0223523425008384"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118073","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoromethylcarnitine, a novel inhibitor of trimethylamine levels in trimethylaminuria and trimethylamine N-oxide related disorders","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118073"}}